Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

New Study Links Air Pollution with Higher Rates of Head and Neck Cancer

A recent study published in Scientific Reports correlates higher levels of pollutant particulate matter to higher occurrences of head and neck aer...

Read More

IN THE NEWS: A Full-Body MRI is the Latest Wellness Status Symbol. Should You Get One in 2025?

GQ Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology  and the  Phas...

Read More

After Helping Her Husband Battle Cancer, Woman Gets Shocking News of Her Own

Mary Lou Brose never imagined having a CT scan of her back could be life-changing, but results from the test turned her world upside down.  A...

Read More
News

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now

WWJ | Karmanos Cancer Institute Hosts Classic Cars for the Cure

Listen Now